News RSS News RSS Feed <![CDATA[Selcia showcased in sp2 Magazine]]> ]]> Wed, 25 Apr 2012 00:00:00 GMT <![CDATA[Selcia and Heptares Therapeutics Announce New Fragment Screening Collaboration]]> Wed, 18 Apr 2012 00:00:00 GMT <![CDATA[Selcia’s fragment based drug discovery platform CEfrag™ showcased at Drug Discovery Chemistry conference, San Diego; and on webinar hosted by EmeraldBioStructures]]> ]]> Tue, 17 Apr 2012 00:00:00 GMT <![CDATA[Selcia Doubles Capacity Of 14C GMP Radiolabelled API Production For Human Studies]]> ]]> Thu, 24 Nov 2011 00:00:00 GMT <![CDATA[New Selcia Fragment Screening Posters]]>
]]> Thu, 29 Sep 2011 00:00:00 GMT <![CDATA[Selcia and NeuroVive to develop new mitochondrial medicines for chronic and acute diseases]]> Mon, 19 Sep 2011 00:00:00 GMT <![CDATA[New Biotech Laboratory Expands Selcia’s US Operation]]> ]]> Mon, 22 Aug 2011 00:00:00 GMT <![CDATA[Selcia in European Pharmaceutical Contractor Magazine June Issue 2011]]> in situ, providing an essential tool for determining the behaviour and fate of chemical compounds in organisms and in the environment.

]]> Tue, 14 Jun 2011 00:00:00 GMT <![CDATA[Simon Bury joins Selcia to expand drug discovery offering]]> ]]> Tue, 31 May 2011 00:00:00 GMT <![CDATA[Selcia and ExonHit Therapeutics announce successful fragment screening collaboration]]> ]]> Mon, 28 Feb 2011 00:00:00 GMT